ED
XYL icon

Exane Derivatives’s Xylem XYL Stock Holding History

Exane Derivatives’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,128
Closed -$96.2K – 1030
2022
Q1 		$96.2K Buy
+1,128
New +$108K 0.03% 477
2021
Q4 		– Sell
-3,545
Closed -$438K – 1080
2021
Q3 		$438K Sell
3,545
-18
-0.5% -$2.32K 0.11% 209
2021
Q2 		$430K Buy
3,563
+917
+35% +$105K 0.1% 217
2021
Q1 		$278K Sell
2,646
-1,143
-30% -$116K 0.08% 238
2020
Q4 		$386K Buy
3,789
+3,780
+42,000% +$355K 0.11% 212
2020
Q3 		$757 Hold
9
– – ﹤0.01% 644
2020
Q2 		$585 Hold
9
– – ﹤0.01% 600
2020
Q1 		$586 Hold
9
– – ﹤0.01% 582
2019
Q4 		$742 Hold
9
– – ﹤0.01% 572
2019
Q3 		$716 Hold
9
– – ﹤0.01% 560
2019
Q2 		$753 Sell
9
-1
-10% -$80 ﹤0.01% 571
2019
Q1 		$790 Sell
10
-1,804
-99% -$132K ﹤0.01% 515
2018
Q4 		$121K Hold
1,814
– – 0.02% 301
2018
Q3 		$146K Sell
1,814
-5
-0.3% -$373 0.03% 278
2018
Q2 		$122K Buy
1,819
+13
+0.7% +$944 0.02% 310
2018
Q1 		$137K Sell
1,806
-22,672
-93% -$1.68M 0.03% 263
2017
Q4 		$1.67M Buy
24,478
+23,004
+1,561% +$1.53M 0.29% 57
2017
Q3 		$92.3K Sell
1,474
-242
-14% -$14.5K 0.02% 275
2017
Q2 		$95.1K Sell
1,716
-19,226
-92% -$1M 0.02% 275
2017
Q1 		$1.05M Buy
+20,942
New +$1.02M 0.24% 87

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Exane Derivatives's XYL Position: Q2 2022 in Review

Exane Derivatives sold out of Xylem (XYL) in Q2 2022, closing a stake of 1,128 shares — an estimated $96.2K sold.

Exane Derivatives first reported a position in XYL in Q1 2017 and held it in 20 quarters. The position peaked at $1.67M in Q4 2017. 725 funds tracked by Wall St. Rank hold XYL as of Q2 2022.

  • Exane Derivatives reported no remaining Xylem position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,128 Xylem shares in Q2 2022, an estimated $96.2K.
  • Exane Derivatives first reported a position in Xylem in Q1 2017 and held it in 20 quarters.
  • Exane Derivatives's Xylem position peaked at $1.67M in Q4 2017.
  • 725 funds tracked by Wall St. Rank held Xylem as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.